ArticleCrohn's & colitis 3602023

Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.

Adriana Zanoni Dotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.